Integral Molecular News

Potent and Efficacious Inhibition of CXCR2 Signaling by Biparatopic Nanobodies Combining Two Distinct Modes of Action

BRADLEY ET AL. 2015. MOL PHARMACOL (87):251–262.

Read More

Upcoming Events

CAR-TCR Summit
8/29 – 9/1 | Boston, MA
 
17th Vaccine Congress
9/24 – 9/27 | Glasgow, Scotland
 
Discovery on Target
9/25 – 9/28 | Boston, MA